Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,462 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at Baseline.
Iwama S, Kobayashi T, Yasuda Y, Okuji T, Ito M, Ando M, Zhou X, Yamagami A, Onoue T, Kawaguchi Y, Miyata T, Sugiyama M, Takagi H, Hagiwara D, Suga H, Banno R, Hase T, Morise M, Wakahara K, Yokota K, Kato M, Nishio N, Tanaka C, Miyata K, Ogura A, Ito T, Sawada T, Shimokata T, Niimi K, Ohka F, Ishigami M, Gotoh M, Hashimoto N, Saito R, Kiyoi H, Kajiyama H, Ando Y, Hibi H, Sone M, Akiyama M, Kodera Y, Arima H. Iwama S, et al. Among authors: ando y, ando m. J Clin Endocrinol Metab. 2022 Mar 24;107(4):e1620-e1630. doi: 10.1210/clinem/dgab829. J Clin Endocrinol Metab. 2022. PMID: 34791304
Phase II study of erlotinib for previously treated patients with EGFR wild-type non-small-cell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System.
Morise M, Taniguchi H, Saka H, Shindoh J, Suzuki R, Kojima E, Hase T, Ando M, Kondo M, Saito H, Hasegawa Y. Morise M, et al. Among authors: ando m. Mol Clin Oncol. 2014 Nov;2(6):991-996. doi: 10.3892/mco.2014.354. Epub 2014 Jul 22. Mol Clin Oncol. 2014. PMID: 25279187 Free PMC article.
Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?
Kato T, Morise M, Ando M, Kojima E, Ogasawara T, Suzuki R, Shindoh J, Matsumoto M, Sugino Y, Ogawa M, Nozaki Y, Hase T, Kondo M, Saito H, Hasegawa Y. Kato T, et al. Among authors: ando m. J Cancer Res Clin Oncol. 2016 Jul;142(7):1629-40. doi: 10.1007/s00432-016-2170-z. Epub 2016 May 11. J Cancer Res Clin Oncol. 2016. PMID: 27166967
Changes in exercise capacity, muscle strength, and health-related quality of life in esophageal cancer patients undergoing esophagectomy.
Inoue T, Ito S, Ando M, Nagaya M, Aso H, Mizuno Y, Hattori K, Nakajima H, Nishida Y, Niwa Y, Kodera Y, Koike M, Hasegawa Y. Inoue T, et al. Among authors: ando m. BMC Sports Sci Med Rehabil. 2016 Nov 3;8:34. doi: 10.1186/s13102-016-0060-y. eCollection 2016. BMC Sports Sci Med Rehabil. 2016. PMID: 27822378 Free PMC article.
Randomized controlled trial for assessment of Internet of Things system to guide intensive glucose control in diabetes outpatients: Nagoya Health Navigator Study protocol.
Onoue T, Goto M, Kobayashi T, Tominaga T, Ando M, Honda H, Yoshida Y, Tosaki T, Yokoi H, Kato S, Maruyama S, Arima H. Onoue T, et al. Among authors: ando m. Nagoya J Med Sci. 2017 Aug;79(3):323-329. doi: 10.18999/nagjms.79.3.323. Nagoya J Med Sci. 2017. PMID: 28878437 Free PMC article. Clinical Trial.
Efficacy of Prophylactic Treatment for Oxycodone-Induced Nausea and Vomiting Among Patients with Cancer Pain (POINT): A Randomized, Placebo-Controlled, Double-Blind Trial.
Tsukuura H, Miyazaki M, Morita T, Sugishita M, Kato H, Murasaki Y, Gyawali B, Kubo Y, Ando M, Kondo M, Yamada K, Hasegawa Y, Ando Y. Tsukuura H, et al. Among authors: ando y, ando m. Oncologist. 2018 Mar;23(3):367-374. doi: 10.1634/theoncologist.2017-0225. Epub 2017 Oct 16. Oncologist. 2018. PMID: 29038236 Free PMC article. Clinical Trial.
Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study.
Kobayashi T, Iwama S, Yasuda Y, Okada N, Tsunekawa T, Onoue T, Takagi H, Hagiwara D, Ito Y, Morishita Y, Goto M, Suga H, Banno R, Yokota K, Hase T, Morise M, Hashimoto N, Ando M, Kiyoi H, Gotoh M, Ando Y, Akiyama M, Hasegawa Y, Arima H. Kobayashi T, et al. Among authors: ando y, ando m. J Endocr Soc. 2018 Feb 6;2(3):241-251. doi: 10.1210/js.2017-00432. eCollection 2018 Mar 1. J Endocr Soc. 2018. PMID: 29600292 Free PMC article.
3,462 results